$RANI
Rani Therapeutics Holdings, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$0.860
▲+0.97%+$0.008
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRani Therapeutics Holdings, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is RANI up today? It is at $0.860 (+0.97%), and our scanner flagged it 17 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RANI spikes, and full due diligence on RANI — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RANI 17 times in the last 30 days. Create a free account to track $RANI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RANI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RANI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystRani Therapeutics Holdings, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Across every filing on file, supply equal to 34.3% of the tradeable float is in play - 34.3% more can still be issued.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
17,196,262 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $18.4M in size · Priced at $1.07/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Imran Mir A Director | Bought (open market) | +36K 0.03% of company | added 1.7% | 2.12M | $25K at $0.690 | Jul 21, 26 |
Imran Talat Officer | Bought (open market) | +35K 0.03% of company | added 8.1% | 470K | $25K at $0.720 | Jul 17, 26 |
Imran Talat Officer | Sold (automatic/other) | -8K | sold 1.8% | 435K | $6K at $0.740 | Jun 27, 26 |
Javadi Alireza Officer | Sold (automatic/other) | -309 | sold 3.2% | 9K | $229 at $0.740 | Jun 27, 26 |
Imran Talat Officer | Sold (automatic/other) | -9K | sold 2.0% | 443K | $7K at $0.810 | Mar 27, 26 |
Javadi Alireza Officer | Sold (automatic/other) | -386 | sold 3.8% | 10K | $301 at $0.780 | Mar 27, 26 |
Imran Talat Officer | Sold (automatic/other) | -9K | sold 1.9% | 452K | $10K at $1.13 | Mar 22, 26 |
Imran Talat Officer | Sold (automatic/other) | -8K | sold 1.7% | 461K | $11K at $1.40 | Dec 27, 25 |
Imran Mir A Director | Bought (open market) | +2.08M 1.8% of company | n/a | 2.08M | $1.3M at $0.600 | Oct 23, 25 |
South Cone Investments Limited Partnership Beneficial Owner (10%) | Sold (automatic/other) | -4.00M 3.5% of company | sold 63% | 2.38M | $11.1M at $2.77 | Oct 21, 25 |
South Cone Investments Limited Partnership Beneficial Owner (10%) | Sold (automatic/other) | -1.92M 1.7% of company | sold 23% | 6.38M | $4.6M at $2.41 | Oct 20, 25 |
Imran Talat Officer | Sold (automatic/other) | -9K | sold 1.9% | 469K | $4K at $0.480 | Sep 27, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on RANI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RANI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RANI last traded at $0.860, up 0.97% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) is next expected to report earnings on Thursday, November 5, 2026, about 48 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RANI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RANI 17 times in the last 30 days.
RANI (Rani Therapeutics Holdings, Inc. Class A Common Stock) trades on XNAS, with a market cap of about $87M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RANI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RANI discussion
Sign in to ask a question or join the discussion.